← Back to Search

Nonsteroidal Anti-inflammatory Drug

Naproxen for Osteoarthritis

N/A
Waitlist Available
Led By Stephen Wright, MD
Research Sponsored by Analgesic Solutions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 weeks
Awards & highlights
All Individual Drugs Already Approved
Approved for 10 Other Conditions

Summary

This study aims to evaluate various methods of measuring pain relief in subjects who have chronic OA of the knee. After a 1 week of wash-out from existing therapy, subjects will be treated in a blinded fashion for 1 week with either naproxen (3 days at 250 mg twice a day followed by 4 days at 500 mg twice a day) or placebo. After the first week of treatment, subjects will have another week of wash-out followed by a second period of 1 week of the alternate treatment. Subjects will not be allowed to use oral non-steroidal anti-inflammatory drugs (NSAIDs) or other oral analgesics, or topical medications on their target knees during the study. Acetaminophen will be allowed as a rescue medication.

Eligible Conditions
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Efficacy of naproxen vs. placebo
Safety

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: NaproxenActive Control2 Interventions
Group II: PlaceboPlacebo Group2 Interventions

Find a Location

Who is running the clinical trial?

Analgesic SolutionsLead Sponsor
8 Previous Clinical Trials
433 Total Patients Enrolled
2 Trials studying Osteoarthritis
75 Patients Enrolled for Osteoarthritis
Stephen Wright, MDPrincipal InvestigatorAnalgesic Solutions
1 Previous Clinical Trials
98 Total Patients Enrolled
~5 spots leftby Nov 2025